Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Invasive Aspergillosis at Hospital H+ Querétaro and the Relationship Between Galactomannan and Clinical Outcomes

NCT07621263 is registered in ClinicalTrials.gov with Hospital H+ Queretaro as lead sponsor.

NCT NCT07621263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07621263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Invasive Aspergillosis at Hospital H+ Querétaro and the Relationship Between Galactomannan and Clinical Outcomes
Lead sponsor
Hospital H+ Queretaro
Phase
Observational
Overall status
Completed
Start date
March 1, 2022
Completion date
March 31, 2026
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invasive aspergillosis